Thursday, July 12, 2012

KaloBios aims its antibodies at an IPO, trio of trials

To that end, KaloBios said this week that it hired former BioMarin Pharmaceutical Inc. executive Jeff Cooper as its first chief financial officer. Cooper is charged with overseeing all that leads up to the South San Francisco company's initial public offering over the next 12 months, said President and CEO David Pritchard.

No comments:

Post a Comment